John Oyler
Chief Executive Officer at BeOne Medicines Ltd.
Sits on 1 board. Last updated September 27, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: BeOne Medicines Ltd., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BeOne Medicines Ltd. June 11, 202698.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | BeOne Medicines Ltd. | Open-market sale | −1,980 | $354.71 | $702,320 |
| Aug 12, 2026 | BeOne Medicines Ltd. | Open-market sale | −2,515 | $356.43 | $896,426 |
| Aug 12, 2026 | BeOne Medicines Ltd. | Open-market sale | −15,396 | $357.63 | $5,506,147 |
| Aug 12, 2026 | BeOne Medicines Ltd. | Open-market sale | −20,899 | $358.41 | $7,490,448 |
| Aug 12, 2026 | BeOne Medicines Ltd. | Open-market sale | −14,102 | $359.12 | $5,064,252 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −13,695 | $359.32 | $4,920,844 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −8,081 | $360.33 | $2,911,849 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −14,569 | $361.47 | $5,266,268 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −11,568 | $362.34 | $4,191,548 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −13,403 | $363.45 | $4,871,344 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −5,211 | $364.31 | $1,898,442 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −3,176 | $365.26 | $1,160,079 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −1,200 | $366.31 | $439,574 |
| Aug 11, 2026 | BeOne Medicines Ltd. | Open-market sale | −4 | $367.00 | $1,468 |
| Aug 10, 2026 | BeOne Medicines Ltd. | Open-market sale | −67 | $350.00 | $23,450 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.